Dyspepsia after cholecystectomy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects must meet all the following inclusion criteria to be enrolled in this study: 1. Age 18-80 (including boundary value), gender unlimited; 2. Cholecystolithiasis was diagnosed by imaging examination and cholecystectomy was performed; 3. Symptoms of dyspepsia (such as anorexia, early satiety, belching, nausea and vomiting, abdominal distension, abdominal pain/abdominal discomfort, diarrhea, reflux, etc.) occur when returning to the hospital after surgery; 4. Researchers believe that taurine ursodeoxycholic acid capsules can be taken when dyspepsia occurs; 5. The subjects expressed informed consent, volunteered to be tested and signed the informed consent form, and agreed to participate in all visits and inspections according to the requirements of the test protocol.
Exclusion criteria
Exclusion criteria: Subjects will be excluded if they meet any of the following conditions: 1. Postoperative dyspepsia caused by other organic diseases; 2. It is complicated with serious disease or mental disease that affects its survival, or known or confirmed active ulcer or duodenal ulcer, or other conditions that are judged by the researcher to be unsuitable for participation in this clinical trial; 3. Those who are allergic to any ingredient contained in taurine ursodeoxycholic acid capsules, or those with allergic constitution.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of dyspepsia symptom score from baseline;Change in quality of life score from baseline;Changes of bile reflux score and gastric mucosa score from baseline; | — |
Countries
China
Contacts
Hunan Provincial People's Hospital